The factor V leiden mutation (R506Q) is not a major risk factor for migrainous cerebral infarction

Cephalalgia

Volumn 17, Issue 5, 1997, Pages 605-607

  Haan, J ^a   Kappelle, L J ^b   De Ronde, H ^a   Ferrari, M D ^a   Bertina, R M ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

Factor V mutation; Migraine; Migrainous cerebral infarction; Resistance to activated protein C

Indexed keywords

ACTIVATED PROTEIN C; BLOOD CLOTTING FACTOR 5;

ADULT; ARTICLE; BLOOD CLOTTING; BRAIN INFARCTION; CLINICAL ARTICLE; FEMALE; GENE MUTATION; HETEROZYGOSITY; HETEROZYGOTE; HUMAN; HUMAN CELL; HUMAN TISSUE; MALE; MIGRAINE; RISK FACTOR;

ADOLESCENT; ADULT; CEREBRAL INFARCTION; FACTOR V; FEMALE; HUMANS; MALE; MIDDLE AGED; MIGRAINE DISORDERS; MUTATION; PROTEIN C; RISK FACTORS;

EID: 0030762172     PISSN: 03331024     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1468-2982.1997.1705605.x     Document Type: Article

References (28)

1. Welch KMA, Levine SR. Migraine-related stroke in the context of the International Headache Society classification of head pain. Arch Neurol 1990;47:458-62
2. Kalendovsky Z, Austin JH. "Complicated migraine": Its association with increased platelet aggregability and abnormal plasma coagulation factors. Headache 1975;15:18-35
3. Levine SR, Joseph R, D'Andrea G, Welch KMA. Migraine and the lupus anticoagulant. Case report and review of the literature. Cephalalgia 1987;7:93-9
4. Levine SR, Welch KMA. The spectrum of neurologic disease associated with antiphospholipid antibodies. Arch Neurol 1987;44:876-83
5. Silvestrini M, Matteis M, Troisi E, Cupini LM, Zaccari G, Bernardi G. Migrainous stroke and the antiphospholipid antibodies. Eur Neurol 1994;34:316-9
6. Dahlback B, Carlsson M, Svensson PJ. Familial thrombophilia due to a previously unrecognized mechanism characterized by poor anticoagulant response to activated protein C: prediction of a cofactor to activated protein C, Proc Natl Acad Sci USA 1993;90:1004-8
7. Bertina RM, Koeleman BPC, Koster T, Rosendaal FR, Dirvert RJ, De Ronde H, et al. Mutation in blood coagulation factor associated with resistance to activated protein C, Nature 1994;369:64-7
8. De Stefano V, Leone G. Resistance to activated protein C due to mutated factor V as a novel cause of inherited thrombophilia. Haematologica 1995;80:344-56
9. Halbmayer WM, Haushofer A, Schon R, Fischer M. The prevalence of poor anticoagulant response to activated protein C (APC resistance) among patients suffering from stroke or venous thrombosis and among healthy subjects. Blood Coagul Fibrinolysis 1994;5:51-7
10. Simioni P, De Ronde H, Prandoni P, Saladini M, Bertina RM, Girolami A. Ischemic stroke in young patients with activated protein C resistance. A report of three cases belonging to three different kindreds. Stroke 1995;26:885-90
11. Cushman M, Bhushan F, Bovill E, Travy R. Plasma resistance to activated protein C in venous and arterial thrombosis. Thromb Haemost 1994;72:647
12. Ridker PM, Hennekens CH, Lindpaintner K, Stampfer MJ, Eisenberg PR, Miletich JP. Mutation in the gene coding for coagulation factor V and the risk of myocardial infarction, stroke and venous thrombosis in apparently healthy men. New Engl J Med 1995;332:912-7
13. Catto A, Carter A, Ireland H, Bayston TA, Philippou H, Barrett J, et al. Factor V Leiden gene mutation and thrombin generation in relation to the development of acute stroke. Arterioscler Thromb Vasc Biol 1995;15:783-5
14. Lalouchek W, Suess E, Aull S, Schnider P, Uhl F, Zeiler K, Pabinger-Fasching I. Clinical and laboratory data in heterozygous factor V Leiden mutation positive versus negative patients with TIA and minor stroke. Stroke 1995;26: 1963-4
15. Forsyth PD, Dolan G. Activated protein C resistance in cases of cerebral infarction. Lancet 1995;345:795
16. Kontula K, Ylikorkala A, Miettinen H, Vuorio A, Kauppinen-Makelin R, Hamalainen L, et al. Arg506Gln factor V mutation (Factor V Leiden) in patients with ischemic cerebrovascular disease and survivors of myocardial infarction. Thromb Haemost 1995;73:558-60
17. Press RD, Liu XY, Beamer N, Coull BM. Ischemic stroke in the elderly. Role of common factor V mutation causing resistance to activated protein C, Stroke 1996;27:44-8
18. Landi G, Cella E, Martinelli I, Tagliabue L, Mannucci PM, Zerbi D. Arg506Gln factor V mutation and cerebral ischemia in young adults. Stroke 1996;27:1697-8
19. Headache Classification Committee of the International Headache Society. Classification and diagnostic criteria for headache disorders, cranial neuralgias and facial pain. Cephalalgia 1988;8 Suppl 7:1-96
20. Narbone MC, Leggiadro N, La Spina P, Rao R, Grugno R, Musolino R. Migraine stroke: A possible complication of both migraine with and without aura. Headache 1996;36:481-3
21. De Ronde H, Bertina RM. Laboratory diagnosis of APC-resistance: a critical evaluation of the test and the development of diagnostic criteria. Thromb Haemost 1994;72:880-6
22. Featherstone HJ. Clinical features of stroke in migraine. Headache 1986;26:128-33
23. Broderick JP, Swanson JW. Migraine-related strokes. Clinical profile and prognosis in 20 patients. Arch Neurol 1987;44: 868-71
24. Rothrock JF, Walicke P, Swenson MR, Lyden PD, Logan WR. Migrainous stroke. Arch Neurol 1988;45:63-7
25. Sacquegna T, Andreoli A, Baldrati A, Lamieri C, Guttmann S, de Carolis P, et al. Ischemic stroke in young adults: The relevance of migrainous infarction. Cephalalgia 1989;9: 255-8
26. Rothrock J, North J, Madden K, Lyden P, Fleck P, Dittrich H. Migraine and migrainous stroke: Risk factors and prognosis. Neurology 1993;43:2473-6
27. Hoekstra-van Dalen RAH, Cillessen JPM, Kappelle LJ, van Gijn J. Cerebral infarcts associated with migraine: Clinical features, risk factors and follow-up. J Neurol 1996;243:511-5
28. Ciusani E, Ariano C, Moschiano F, Grazzi L, D'Amico D, Nespolo A, Bussone G. Point mutation (Arg506-Gln) of factor V in migraine with and without aura [Abstract]. Cephalalgia 1996;16:394